Oncogene - Table of Contents alert Volume 33 Issue 37

If you are unable to see the message below, click here to view.

Advertisement Pure epigenetics innovation. Unique validated antibodies and ChIP-seq expertise: Only provider of CAS9/CRISPR antibody  Hundreds of validated antibodies for ChIP-seq  ChIP-seq from just 10,000 cells TABLE OF CONTENTS Volume 33, Issue 37 (September 2014) In this issue Review Original Articles Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Our Impact Factor has increased! Oncogene celebrates a new, higher Impact Factor of 8.559*. Thank you for your support!  Subscribe to Oncogene and you'll never have to miss the latest developments in cancer research. *2013 Journal Citation Report® (Thomson Reuters, 2014)   Review Top SRChing for the substrates of Src A B Reynolds, S B Kanner, A H Bouton, M D Schaller, S A Weed, D C Flynn and J T Parsons Oncogene 2014 33: 4537-4547; advance online publication, October 14, 2013; 10.1038/onc.2013.416 Abstract | Full Text Original Articles Top mTORC1/2 targeted by n-3 polyunsaturated fatty acids in the prevention of mammary tumorigenesis and tumor progression Z Chen, Y Zhang, C Jia, Y Wang, P Lai, X Zhou, Y Wang, Q Song, Jun Lin, Z Ren, Q Gao, Z Zhao, H Zheng, Z Wan, T Gao, A Zhao, Y Dai and X Bai Oncogene 2014 33: 4548-4557; advance online publication, October 7, 2013; 10.1038/onc.2013.402 Abstract | Full Text HOXB13 downregulates intracellular zinc and increases NF-κB signaling to promote prostate cancer metastasis Y-R Kim, I-J Kim, T W Kang, C Choi, K K Kim, M S Kim, K I Nam and C Jung Oncogene 2014 33: 4558-4567; advance online publication, October 7, 2013; 10.1038/onc.2013.404 Abstract | Full Text Targeting Epstein–Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy OPEN L Xiao, Z-y Hu, X Dong, Z Tan, W Li, M Tang, L Chen, L Yang, Y Tao, Y Jiang, J Li, B Yi, B Li, S Fan, S You, X Deng, F Hu, L Feng, A M Bode, Z Dong, L-q Sun and Y Cao Oncogene 2014 33: 4568-4578; advance online publication, March 24, 2014; 10.1038/onc.2014.32 Abstract | Full Text Identification of MAGEA antigens as causal players in the development of tamoxifen-resistant breast cancer OPEN P-P Wong, C C Yeoh, A S Ahmad, C Chelala, C Gillett, V Speirs, J L Jones and H C Hurst Oncogene 2014 33: 4579-4588; advance online publication, March 24, 2014; 10.1038/onc.2014.45 Abstract | Full Text Phosphatidylethanolamine-binding protein 4 is associated with breast cancer metastasis through Src-mediated Akt tyrosine phosphorylation H Li, F Huang, L Fan, Y Jiang, X Wang, J Li, Q Wang, H Pan, J Sun, X Cao and X Wang Oncogene 2014 33: 4589-4598; advance online publication, November 25, 2013; 10.1038/onc.2013.408 Abstract | Full Text p21 suppresses inflammation and tumorigenesis on pRB-deficient stratified epithelia C Saiz-Ladera, M F Lara, M Garín, S Ruiz, M Santos, C Lorz, R García-Escudero, M Martínez-Fernández, A Bravo, O Fernández-Capetillo, C Segrelles and J M Paramio Oncogene 2014 33: 4599-4612; advance online publication, October 14, 2013; 10.1038/onc.2013.417 Abstract | Full Text Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes OPEN M Aga, G L Bentz, S Raffa, M R Torrisi, S Kondo, N Wakisaka, T Yoshizaki, J S Pagano and J Shackelford Oncogene 2014 33: 4613-4622; advance online publication, March 24, 2014; 10.1038/onc.2014.66 Abstract | Full Text Advertisement SPECIAL SAVINGS: Latest lab equipment and services Discover the resource everyone is using! Before you buy, VISIT MARKETPLACE  Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.